0001214659-20-004966.txt : 20200522 0001214659-20-004966.hdr.sgml : 20200522 20200522210657 ACCESSION NUMBER: 0001214659-20-004966 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200520 FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finn Patrick John CENTRAL INDEX KEY: 0001755970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 20907765 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-48851.xml PRIMARY DOCUMENT X0306 4 2020-05-20 0001581280 Twist Bioscience Corp TWST 0001755970 Finn Patrick John C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false Chief Commercial Officer Common Stock 2020-05-20 4 S false 3508 39.5561 D 36698 D Common Stock 2020-05-20 4 S false 599 40.2126 D 36099 D Common Stock 2020-05-20 4 S false 100 41.07 D 35999 D Common Stock 2020-05-20 4 F false 675 39.76 D 35324 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Represents the weighted average sales price per share. The shares sold at prices ranging from $38.96 to $39.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Represents the weighted average sales price per share. The shares sold at prices ranging from $40.04 to $40.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). /s/ William Solis, as Attorney-in-Fact for Patrick John Finn 2020-05-22